Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/13/23 16:07 | 6/9/23 | COGT | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | TH | See Rema | P.d | 9,600 | 12.00 | 0 | 800 | 29 | 3,559 | I | ||||||||||||||
6/21/22 10:02 | 6/16/22 | COGT | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | TH | See Rema | P.d | 9,900 | 8.25 | 0 | 1,200 | 77 | 2,759 | I | ||||||||||||||
8/18/20 18:19 | 8/14/20 | UMRX | Health | Drug | Pharmaceutical Preparations | Venrock Healthcare Capital Partners Iii, L.P. | NY | T | P.m | 1,137 | 2.52 | 0 | 451 | 12 | 4,355 | I | |||||||||||||||
4/5/18 12:27 | 4/3/18 | UMRX | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | H | See Rema | P.d | 1,129 | 12.00 | 0 | 94 | 4 | 2,413 | I | ||||||||||||||
4/3/18 17:11 | 4/3/18 | UMRX | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Ix, L.P. | MA | T | P.d | 1,129 | 12.00 | 0 | 94 | 3 | 3,362 | D | |||||||||||||||
4/3/18 17:07 | 4/3/18 | UMRX | Health | Drug | Pharmaceutical Preparations | Booth Bruce | MA | D | P.d | 1,129 | 12.00 | 0 | 94 | 3 | 3,362 | I | |||||||||||||||
4/3/18 16:30 | 4/3/18 | UMRX | Health | Drug | Pharmaceutical Preparations | Ratcliffe Liam | MA | D | P.d | 6,600 | 12.00 | 0 | 550 | 158 | 898 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |